Regulation & governance

Myeloma Gets an Accelerated Approval. The Endpoint Is the Politics.

Parkinson’s Gets Fast Track, Not Fast Proof

America Has Already Passed Last Year’s Measles Total.

Anxiety Gets a Psychedelic Trial, Not a Shortcut

345 Salmonella Cases Later, The Supply Chain Is Still Being Reconstructed.

Antidepressant Trials Still Leave People Out

ALS Biomarkers Are Entering the Approval Fight

The first oral PCSK9 inhibitor is approved. A pill will not fix cholesterol access by itself

Oral GLP-1 drugs could widen access, but high prices may do the opposite
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
